409 related articles for article (PubMed ID: 3155462)
41. Reduction of Foxp3-expressing regulatory T cell infiltrates during the progression of renal allograft rejection in a mouse model.
Wang S; Jiang J; Guan Q; Lan Z; Wang H; Nguan CY; Jevnikar AM; Du C
Transpl Immunol; 2008 May; 19(2):93-102. PubMed ID: 18503884
[TBL] [Abstract][Full Text] [Related]
42. Association of chronic thromboxane inhibition with reduced in situ cytotoxic T cell activity in rejecting rat renal allografts.
Ruiz P; Coffman TM; Klotman PE; Sanfilippo F
Transplantation; 1989 Oct; 48(4):660-6. PubMed ID: 2799920
[TBL] [Abstract][Full Text] [Related]
43. Immune monitoring after renal transplantation. I. HLA-D expression on T cells from renal allograft recipients.
Nowaczyk M; Górski A; Modlińska M; Rancewicz Z; Bukowska J; Ołdakowska U; Morzycka-Michalik M; Lao M
Arch Immunol Ther Exp (Warsz); 1991; 39(3):291-6. PubMed ID: 1667260
[TBL] [Abstract][Full Text] [Related]
44. The effect of rhGH in vitro on donor-specific hyporesponsiveness in pediatric transplantation.
Benfield MR; Vail A; Waldo FB; Bucy RP; Kohaut EC
Pediatr Transplant; 1997 Aug; 1(1):90-7. PubMed ID: 10084793
[TBL] [Abstract][Full Text] [Related]
45. Function and surface phenotype of T lymphocytes infiltrating renal allografts in nonhuman primates treated with monoclonal antibodies.
Nocera A; Cosimi AB; Colvin RB; Gesner ML; Fuller TC
Transplantation; 1989 Nov; 48(5):732-41. PubMed ID: 2573179
[TBL] [Abstract][Full Text] [Related]
46. [Immunology of transplantation].
Chatenoud L; Bach JF
Arch Fr Pediatr; 1988; 45 Suppl 1():693-7. PubMed ID: 2977090
[TBL] [Abstract][Full Text] [Related]
47. Renal allograft-infiltrating lymphocytes. A prospective analysis of in vitro growth characteristics and clinical relevance.
Kirk AD; Ibrahim MA; Bollinger RR; Dawson DV; Finn OJ
Transplantation; 1992 Feb; 53(2):329-38. PubMed ID: 1371194
[TBL] [Abstract][Full Text] [Related]
48. Immunology of renal allograft rejection.
Ratner LE; Hadley GA; Hanto DW; Mohanakumar T
Arch Pathol Lab Med; 1991 Mar; 115(3):283-7. PubMed ID: 2001169
[TBL] [Abstract][Full Text] [Related]
49. Identity and cytotoxic capacity of cells infiltrating renal allografts.
Strom TB; Tilney NL; Carpenter CB; Busch GJ
N Engl J Med; 1975 Jun; 292(24):1257-63. PubMed ID: 1093024
[TBL] [Abstract][Full Text] [Related]
50. Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts.
Cosimi AB; Colvin RB; Burton RC; Rubin RH; Goldstein G; Kung PC; Hansen WP; Delmonico FL; Russell PS
N Engl J Med; 1981 Aug; 305(6):308-14. PubMed ID: 6454075
[TBL] [Abstract][Full Text] [Related]
51. Immune status assay (ISA): a noninvasive procedure for studying allograft rejection.
Fernandez LA; Tsuchida M; Manthei E; Fechner JH; Oberley TD; Leverson GE; Knechtle SJ; Hamawy MM
Transpl Immunol; 2004; 13(2):147-54. PubMed ID: 15380545
[TBL] [Abstract][Full Text] [Related]
52. Ex vivo propagation and characterization of lymphocytes from rejecting rat-kidney allografts.
Engstrand M; Johnsson C; Korsgren O; Tufveson G
Transpl Immunol; 1999 Dec; 7(4):189-96. PubMed ID: 10638830
[TBL] [Abstract][Full Text] [Related]
53. Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers.
Bishop GA; Hall BM; Duggin GG; Horvath JS; Sheil AG; Tiller DJ
Kidney Int; 1986 Mar; 29(3):708-17. PubMed ID: 2939279
[TBL] [Abstract][Full Text] [Related]
54. [Phenotype and function of cells infiltrating rat renal allograft].
Hamashima T
Nihon Geka Gakkai Zasshi; 1990 Mar; 91(3):393-400. PubMed ID: 2193222
[TBL] [Abstract][Full Text] [Related]
55. Renal allograft rejection: protection of renal tubular epithelial cells from lymphokine activated killer cell mediated lysis by pretreatment with cytokines.
Kirby JA; Forsythe JL; Simm A; Proud G; Taylor RM
Nephrol Dial Transplant; 1989; 4(9):824-8. PubMed ID: 2483256
[TBL] [Abstract][Full Text] [Related]
56. In vitro propagation of tissue-infiltrating lymphoid cells from lesional skin by culture in IL 2-containing medium.
Aiba S; Tagami H
Acta Derm Venereol; 1986; 66(5):391-7. PubMed ID: 2431575
[TBL] [Abstract][Full Text] [Related]
57. Anti-B lymphocytotoxins in renal-allograft rejection.
Ettenger RB; Terasaki PI; Ting A; Malekzadeh MH; Pennisi AJ; Uittenbogaart C; Garrison R; Fine RN
N Engl J Med; 1976 Aug; 295(6):305-9. PubMed ID: 778617
[TBL] [Abstract][Full Text] [Related]
58. Endothelial and smooth muscle cells in the heart allograft response: isolation procedure and immunocytochemical features.
Wijngaard PL; de Bresser JM; de Groot PG; Gmelig-Meyling FH; Schuurman HJ; Jambroes G; Borleffs JC
J Heart Lung Transplant; 1991; 10(3):416-23. PubMed ID: 1830221
[TBL] [Abstract][Full Text] [Related]
59. Effector T-cell repertoire selection in human allograft rejection.
Finn OJ; Miceli MC
Transplant Proc; 1989 Feb; 21(1 Pt 1):346-8. PubMed ID: 2495608
[No Abstract] [Full Text] [Related]
60. Direct cell mediated lympholysis by peripheral blood lymphocytes from renal allograft recipients.
Grunnet N; Kristensen T
Scand J Urol Nephrol; 1975 Mar 6-7; (29 Suppl):41-4. PubMed ID: 133456
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
